Table: Shin Nippon Biomedical -2017/18 group results

Shin Nippon Biomedical Laboratories

15/05/2018 07:00

May 15 (Reuters)- 
          Shin Nippon Biomedical Laboratories Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to         NEXT     
              Mar 31, 2018    Mar 31, 2017    Mar 31, 2019       YEAR       
                 LATEST         YEAR-AGO         COMPANY         COMPANY    
                 RESULTS         RESULTS        FORECAST       H1 FORECAST  
  Sales           16.60           17.24           16.70           7.57      
               (-3.7 pct)      (+16.9 pct)     (+0.6 pct)      (+0.3 pct)   
  Operating   loss 697 mln      loss 1.79     loss 520 mln    loss 765 mln  
  Recurring   loss 813 mln      loss 2.11     loss 700 mln    loss 932 mln  
  Net
  Net           loss 3.56     loss 915 mln      loss 1.16       loss 1.29   
  EPS        loss 85.41 yen  loss 22.18 yen  loss 27.79 yen  loss 30.86 yen 
  Ann Div          NIL             NIL                                      
  -Q2 Div          NIL             NIL                                      
  -Q4 Div          NIL             NIL                                      
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T